Scouting for New Deals

Like animals in the wild searching for food, a biotech company pretty much has the same daily need - except it's for funding. Ben Fidler of Xconomy shares the latest hunting efforts of Ensemble Therapeutics based in Cambridge in the feature "Ensemble Quietly Amasses Cancer Drug Pipeline, Scouts for New Deals" - the intro: "It’s [...]

March 9th, 2016|

Nestlé Invests in Pronutria

Coverage of Nestlé Health's $42.5M investment in Pronutria: Pronutria Biosciences Announces $42.5 Million Equity Investment from Nestlé Health Science (pr) Pronutria, Eyeing Clinical Push, Gets $42.5M From Nestle Health (Xconomy) Nestlé puts $43M into Cambridge's Pronutria to make food-based disease treatments (BioFlash) Nestlé pays $42.5M to buy into Pronutria as it blazes a trail to [...]

February 25th, 2016|

Yumanity Secures $45M

Excerpts/coverage of Yumanity obtaining $45M from multiple investors: "Yumanity Therapeutics, a company focused on transforming drug discovery for diseases caused by protein misfolding, today announced a $45 million Series A financing from leading life sciences investors. The financing is being led by Fidelity Management & Research Company with participation by Redmile Group, Alexandria Venture Investments, [...]

February 10th, 2016|

Biotechs That Held IPOs in 2015

Excerpt from Don Seiffert for BioFlash/Boston Business Journal: "This year’s wrap-up of initial public offerings by IPO research firm Renaissance Capital calls the year “a disappointment,” with the $30 billion raised across all sectors at a six-year low. But you wouldn’t know it here in Massachusetts, where 11 biotechs went public since Jan. 1 — [...]

December 17th, 2015|

One of the Hottest Spots for Biotech Jobs

GEN has its new list of hubs that are "hot spots" for biotech jobs, and while there's no ranking of the hubs, Boston (along with the other Big3Bio regions) is highlighted as one of the top in the country. From GEN/Editor Alex Philippidis: "GEN generated its list of the top 10 U.S. regions in which to [...]

November 30th, 2015|

Ex-Biogen Exec’s Startup Gets $80M

Coverage of Codiak BioSciences, with ex-Biogen exec Doug Williams as CEO, launching today in Cambridge: Xconomy: Big Bucks, Tiny Bubbles: Ex-Biogen Exec’s Exosome Startup Nabs $80M "Codiak is launching today in Cambridge, MA, with the backing of venture firms Flagship Ventures and Arch Venture Partners, Fidelity Management & Research, the venture arm of Alexandria Real Estate [...]

November 17th, 2015|

Astellas to Acquire Ocata Therapeutics

Excerpts from coverage of the recent news of Astellas acquiring Ocata Therapeutics: BioFlash: Marlborough stem cell pioneer Ocata attracts buyout bid for nearly double its value "Japanese drugmaker Astellas Pharma announced late Monday night that it’s offering $8.50 per share in cash to buy Ocata (Nasdaq: OCAT), a company that attracted worldwide attention just over a [...]

November 10th, 2015|